FDA’s Twitter Formula Allows Tweets About Products Without Excessive Risks
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s draft guidance on presenting product information on social media platforms with character space limitations includes an equation for sending a tweet.
You may also be interested in...
Senators Pressure US FDA To Issue New Guidance On Social Media Drug Promotion
Senators ask the agency to address the “regulatory loophole” permitting telehealth companies to promote prescription drugs without disclosing side effects and question if FDA has enforcement authority over third-party social media influencer promotions.
Pfizer’s Paxlovid And The Murky World Of Rx Drug Communication
Pfizer social media announcement that it’s seeking full approval for the oral COVID antiviral raise questions about where the line is on promotion versus other communications, FDA’s ability to regulate pharma on social media, and the unique considerations of promotion under EUAs.
Pfizer’s Paxlovid And The Murky World Of Rx Drug Communication
Pfizer social media announcement that it’s seeking full approval for the oral COVID antiviral raise questions about where the line is on promotion versus other communications, FDA’s ability to regulate pharma on social media, and the unique considerations of promotion under EUAs.